A study conducted by the University of Copenhagen, Denmark, examined whether consumption of probiotics can aid young children with atopic dermatitis, also known as eczema.
Source: R Gobel et al., “Probiotics to young children with atopic dermatitis: a randomized placebo-controlled trial,” International Journal of Probiotics and Prebiotics, vol. 5, no. 2 (2010): 53-60.
A study conducted by the University of Copenhagen, Denmark, examined whether consumption of probiotics can aid young children with atopic dermatitis, also known as eczema.
The double-blind, randomized, placebo-controlled intervention was performed on 50 children between the ages of 7 months and 24 months. For eight weeks, subjects were given supplements of Danisco’s (Copenhagen) probiotic strains Lactobacillus acidophilus NCFM (1010 CFU/day) or Bifidobacterium animalis Bi-07 (1010 CFU/day) or placebo. Immunological activity and clinical effects were evaluated by measures including the standardized Scoring Atopic Dermatitis (SCORAD) index, as well as IgE, ECP, IL-10, IFN-y, IL-31, and faecal calprotectin.
Researchers determined, through SCORAD results, that the group supplemented with Bifidobacterium animalis Bi-07 saw significant reduction in the severity of atopic dermatitis, as well as an improved ratio of IFN-y and IL-10.
“The study shows that there may be a role for certain probiotics in the management of atopic dermatitis,” commented Arthur Ouwehand, PhD, group manager, health and nutrition, for Danisco.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.